Saturday 23 February 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
February
(45)
- FDA needs more funds
- China says: buyer beware
- Cobra in SARS protein deal
- Lonza reclassified as life sciences and biotechnol...
- FDA needs budget boost
- Evonik plans IPO and sale
- Shasun signs Merck deal
- Genmab addresses manufacturing need
- Arch looks to Europe
- New powers for FDA proposed
- Jubilant Organosys has signed manufacturing contra...
- Evonik postpones IPO seeks buyer
- Cambrex facing fine after October fire
- Call for inspections law change
- BASF sees higher fine chems earnings
- Bids come in for Chemtura
- FDA inspected wrong plant
- Call for FDA head to resign
- Record for Cambrex
- AZ spins off GI research
- DSM to buy and sell
- Saltigo has officially inaugurated its state-of-th...
- SAFC grows in 2007
- Financial sources pour cold water on rumoured BASF...
- Chiral product supplier Celtic Catalysts won the "...
- Flat year at DSM
- AstraZeneca may spin off GI research
- BASF chief executive, Jurgen Hambrecht, discusses ...
- DSM Pharmaceuticals will manufacture commercial dr...
- Cambridge Major adds capacity
- American Pacific Fine Chemicals sees increased rev...
- 3i buys Alpharma API biz
- Helsinn has added a small scale cGMP pilot plant i...
- Sumitomo Chemical sees nine-month fine chems sales...
- Quintessence Biosciences has chosen Althea Technol...
- Budget increase for FDA
- Laureate Pharma will manufacture Arius Research's ...
- Carbogen Amcis will perform pre-clinical process d...
- Papers: Give the FDA money and people
- Rumour: BASF interested in acquiring Albemarle
- More Indian plants for AMRI
- WuXi PharmaTech has completed its acquisition of b...
- CiVentiChem adds pilot plant in India
- Jubliant Organosys attributes 40% profit rise to c...
- Albemarle will manufacture the API for Anthera Pha...
-
▼
February
(45)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment